Valneva SE (FRA:AYJ)
2.370
-0.074 (-3.03%)
At close: Jun 23, 2025, 10:00 PM CET
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
€260,950
Profits / Employee
€112,746
Market Cap
408.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Siemens Energy AG | 98,000 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Siemens Healthineers AG | 72,000 |
Valneva SE News
- 19 days ago - UK's MHRA suspends Valneva's chikungunya vaccine for elderly - Reuters
- 23 days ago - Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026 - Benzinga
- 23 days ago - Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ - Wallstreet:Online
- 23 days ago - Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® - GlobeNewsWire
- 25 days ago - Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Valneva to Participate at U.S. and European Investor Conferences in June - GlobeNewsWire
- 6 weeks ago - Valneva Provides Update on Recommended Use of IXCHIQ by Elderly Individuals in the United States - Wallstreet:Online
- 6 weeks ago - Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States - GlobeNewsWire